稳健医疗跌4.54% 2020年上市超募21亿元

Core Viewpoint - The stock of Shengjian Medical (300888.SZ) has experienced a decline of 4.54%, currently trading at 36.35 yuan, indicating it is in a state of breaking its initial public offering price [1] Group 1: IPO Details - Shengjian Medical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on September 17, 2020, with an issuance of 50 million shares at a price of 74.30 yuan per share [1] - The total funds raised by Shengjian Medical amounted to 3.715 billion yuan, with a net amount of 3.559 billion yuan after deducting issuance costs, which was 2.133 billion yuan more than the original plan [1] - The company initially aimed to raise 1.426 billion yuan for projects including high-end dressing production line construction, marketing network development, research and development center establishment, and digital management system project [1] Group 2: Underwriting and Fees - The underwriting institution for Shengjian Medical's IPO was China International Capital Corporation, with representatives Shen Lulu and Wang Haonan [1] - The total issuance costs were 156 million yuan, of which the underwriting fee for China International Capital Corporation was 123 million yuan [1] Group 3: Dividend Distribution - On May 27, 2023, Shengjian Medical announced its 2022 annual equity distribution plan, proposing a cash dividend of 19.00 yuan (including tax) for every 10 shares, along with a capital increase of 4 shares for every 10 shares held, without issuing bonus shares [1]